Skip to main content
. 2021 Jul 14;1:13. doi: 10.1038/s43856-021-00012-4

Fig. 4. Symptoms, age and gender distribution of participants with neutralising antibodies.

Fig. 4

Individual symptoms (a), correlation of the the number of symptoms with the neutralisation test (NT 1:X) result (b), distribution with regard to age group (c) and gender (d) among participants with neutralising antibodies evaluated in sera from the initial blood draw (day 0; n = 41). Neutralisation test (NT).